Rui Su
苏睿
Rui Su is the founder and CEO of SynMetabio (贻如生物), a Shanghai-based synthetic biology startup founded around December 2021 that develops 100% bio-based leather . A Shanghai University of Science and Technology alum who came out of an iGEM (International Genetically Engineered Machine Competition) background, Su initially explored various directions including skincare ingredients before zeroing in on synthetic biology applications for leather with Linear Capital's guidance . As of early 2024 he was described as the youngest founder in Linear Capital's portfolio . SynMetabio has raised multiple rounds including an angel round led by Linear Capital and a subsequent Pre-A in the tens of millions of RMB, with Su citing major cost reductions through strain development, feedstock selection, and fermentation process optimization .
AI-generated — may contain errors, please verify.
Coverage
He Started a Business at 20, and Now He's Selling Mushroom-Grown Leather to the World | Linear Voice
SynBioTech announced the completion of a Series A funding round exceeding 100 million yuan.
AI4S Doesn't Lack Stories; It Lacks Real Commercial Value | Linear Voice
"Discovery" is often not the hardest part.
After the Start of Summer, Growing Without Reserve | Linear Quarterly
Abundant sunshine, lush growth.
Linear Voice: 2025 in the Linear Capital Network
Those real and important moments.
Linear Capital's angel-round lead investment project, *SynMetabio*, has raised tens of millions of RMB in a Pre-A round, with existing investor Linear Capital continuing to double down as a follow-on investor.
The cost of bio-based leather manufacturing has dropped sharply, and a commercial inflection point could arrive next year, with tens of millions of yuan in revenue.
"贻如生物" Su Rui: How the World's First Continuously Produced 100% Bio-based Leather Was Achieved | Linear Capital Portfolio Interview Series
Today, SynMetabio, a Linear Capital seed-round lead portfolio company, announced it has raised tens of millions of RMB in a Pre-A round. One year after announcing its seed round from Linear Capital in April 2023, SynMetabio has made significant progress, **including optimizing its entire production process, substantially reducing manufacturing costs, and achieving cost advantages for bio-based materials in most application scenarios.** Next, SynMetabio will build a factory in Changzhou to scale up mass production of its synthetic leather.
Synthetic biology startup **SynBioRay** (贻如生物) has raised tens of millions of RMB in funding, with **Linear Capital** leading the angel round.
Using synthetic biotechnology to cultivate 100% bio-based leather.
